Dr. Ronald Copeland, president and executive director of Ohio Kaiser Permanente Medical Group, spoke on the importance of emphasizing health awareness on a community level. He touched on key benefits in developing personalized medicine including the ability to make more informed medical decisions, decreased probability of negative side effects and early disease intervention.
Copeland continued to say that we must proceed with caution and realize these benefits in a way that allows them to be both impactful and sustainable. It seems likely that the genetic influences and impacts on disease are great and additional research is going to be a key factor. We need to improve quality and patient satisfaction while reducing health care costs. Copeland ended his presentation by noting that there is definitely a case for practicing and researching personalized medicine and that he and his team are pleased to be part of the journey and look forward to collaborating on future discoveries.
No comments:
Post a Comment